We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IRWD market cap is 1.27B. The company's latest EPS is USD -6.4029 and P/E is -1.27.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 108.64M | 107.2M | 104.06M | 107.38M | 113.74M |
Operating Income | 68.47M | 68.36M | 60.1M | -1.08B | 40.02M |
Net Income | 50.32M | 48.87M | 45.71M | -1.06B | 15.32M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 431.94M | 389.52M | 413.8M | 410.6M | 442.74M |
Operating Income | 116.95M | 142.94M | 232.26M | 250.34M | -945.43M |
Net Income | 21.51M | 106.18M | 528.45M | 175.07M | -1B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.04B | 1.1B | 1.16B | 603.22M | 524.06M |
Total Liabilities | 449.28M | 448.14M | 448.43M | 950M | 849.74M |
Total Equity | 591.06M | 652.38M | 706.85M | -346.78M | -325.68M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 402.75M | 559.24M | 1.13B | 1.1B | 471.07M |
Total Liabilities | 496M | 496.6M | 521.02M | 448.14M | 817.37M |
Total Equity | -93.25M | 62.64M | 605.91M | 652.38M | -346.3M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 194.58M | 273.76M | 80.17M | 115.13M | 147.59M |
Investing | -163k | -136k | -13k | -999.51M | -1.02B |
Financing | -240.36M | -237.55M | 3.98M | 403.05M | 328.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 10.73M | 168.84M | 261.9M | 273.76M | 183.43M |
Investing | -11.14M | -1.84M | -265k | -136k | -1.03B |
Financing | -1.19M | 18.55M | -4.55M | -237.55M | 277.16M |
Market Cap | 1.27B |
Price to Earnings Ratio | -1.27 |
Price to Sales Ratio | 2.87 |
Price to Cash Ratio | 13.78 |
Price to Book Ratio | -3.67 |
Dividend Yield | - |
Shares Outstanding | 156.53M |
Average Volume (1 week) | 2.74M |
Average Volume (1 Month) | 2.53M |
52 Week Change | -22.86% |
52 Week High | 15.70 |
52 Week Low | 7.53 |
Spread (Intraday) | 0.22 (2.64%) |
Company Name | Ironwood Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.ironwoodpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions